Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.

Madelain V, Mentré F, Baize S, Anglaret X, Laouénan C, Oestereich L, Nguyen THT, Malvy D, Piorkowski G, Graw F, Günther S, Raoul H, de Lamballerie X, Guedj J

Open source

DOI: 10.1002/psp4.12510
Published: 2020 May
Container: CPT: pharmacometrics & systems pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/psp4.12510,
  title = {Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.},
  author = {Madelain V and Mentré F and Baize S and Anglaret X and Laouénan C and Oestereich L and Nguyen THT and Malvy D and Piorkowski G and Graw F and Günther S and Raoul H and de Lamballerie X and Guedj J},
  year = {2020},
  journal = {CPT: pharmacometrics \& systems pharmacology},
  doi = {10.1002/psp4.12510},
  url = {https://doi.org/10.1002/psp4.12510}
}

RIS

TY  - JOUR
TI  - Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.
AU  - Madelain V
AU  - Mentré F
AU  - Baize S
AU  - Anglaret X
AU  - Laouénan C
AU  - Oestereich L
AU  - Nguyen THT
AU  - Malvy D
AU  - Piorkowski G
AU  - Graw F
AU  - Günther S
AU  - Raoul H
AU  - de Lamballerie X
AU  - Guedj J
PY  - 2020
JO  - CPT: pharmacometrics & systems pharmacology
DO  - 10.1002/psp4.12510
UR  - https://doi.org/10.1002/psp4.12510
ER  -

APA

V, M., F, M., S, B., X, A., C, L., L, O., THT, N., D, M., G, P., F, G., S, G., H, R., X, D. L., & J, G. (2020). Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.. CPT: pharmacometrics & systems pharmacology. https://doi.org/10.1002/psp4.12510

Source records

pubmed · retrieved 2026-09-26T20:29:14.746Z